Denali Therapeutics Inc. (DNLI) Climbed 5.02% or 1.03 To Price $21.53 On Wednesday

Denali Therapeutics Inc. (DNLI) climbed 5.02% or 1.03 to $21.53. It is approximately 200000 shares traded, which is 48.43% compare to the average total volume 412988. The market cap of DNLI is $2.06 billion. The year to date change is 11.08%. The 52 week price range is from $12.32 to $28.86. Price of DNLI have changed -12.88% during last week. It have changed -24.83% over last month, 2.60% over last 3 months, 18.70% over last 6 months and 9.63% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 23.87. It is 10.87% above current price. The 200-day Moving Averages for DNLI is 19.83. It is -7.90% below current price. The 52-week High is 28.86. It is 34.05% from the current price. The 52-week Low is 12.32. It is -42.78% from current price.

There are some statistics of DNLI. It is has market cap $2.06 billion. The share outstanding is 95.48 million. The average volume is 412988. The percent of top 15 Institution holding is 86.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -7.30%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -6.43%.


Share this post